OMNILIFE opens $64M manufacturing hub in Texas

OMNILIFE has opened a new $64 million-plus Innovation Park in Allen, Texas, giving the supplement company its first U.S. manufacturing plant and a combined headquarters, distribution, and production site. The move expands North American capacity and is aimed at supporting growth in the U.S. market.

Why it matters: - OMNILIFE now has a manufacturing base inside the United States, which shortens the path between production and U.S. customers. - The Allen site expands the company’s North American footprint and adds manufacturing capacity across Mexico, Colombia, and the United States. - The project is designed to support long-term U.S. growth in dietary supplements and personal care.

What happened: - OMNILIFE opened OMNILIFE Innovation Park in Allen, Texas, with an investment of more than $64 million. - The 550,000-square-foot complex combines the company’s U.S. headquarters, a nationwide distribution center, and OMNILIFE’s first manufacturing plant on U.S. soil. - The new plant has started producing part of the portfolio for the U.S. market, while Mexico and Colombia continue supplying the rest of demand. - The company has operated for 35 years and sells in more than 20 countries.

The details: - The first phase of the plant focuses on powdered dietary supplements. - Initial output is more than half a million units per year. - The line can nearly double production without adding infrastructure. - The site includes space reserved for additional production lines and new product categories. - The plant uses servo-controlled dosing, automated filling, ISO 7 and ISO 8 areas, and an on-site microbiology and analysis laboratory. - Operations follow the applicable U.S. regulatory framework and good manufacturing practices. - Allen was chosen for its location in the Dallas–Fort Worth corridor and its access to the broader U.S. market. - OMNILIFE says the U.S. is one of the world’s most important markets for dietary supplements and direct selling, and its third-largest market by sales volume.

Between the lines: - The Texas investment signals a shift from relying mainly on manufacturing in Latin America to a more localized U.S. supply model. - The company is also adapting product labels and some product names for the U.S. market while keeping formulas and product benefits unchanged. - OMNILIFE is working with specialists, researchers, and academic institutions to expand evidence on finished products and ingredients. - The LEAN-built facility includes LED lighting, efficient electrical systems, green areas, and measures to reduce waste and improve energy and water use. - Consolidating manufacturing, storage, and distribution on one site should improve logistics efficiency and simplify operations.

What’s next: - OMNILIFE expects the Allen investment to support projected U.S. growth and strengthen its long-term presence in the country. - The company has reserved space at the site for future production lines and product categories. - The facility is expected to create direct and indirect jobs and deepen the local supplier network. - The Allen site will also serve as a gathering place for OMNILIFE’s distributor community in the United States.

The bottom line: - OMNILIFE is betting that a U.S. manufacturing foothold will help it grow faster, respond more quickly to demand, and build a more resilient North American supply chain.